Hematological stem cell transplantation

DRUG2 trials

Sponsors

Rambam Health Care Campus, Wuhan Sian Medical Technology Co., Ltd

Conditions

Acute Lymphoblastic LeukemiaB Cell LymphomaBusulfan Pharmacokinetic AnalysisGST Genetic Polymorphism

Phase 1

Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies

Wuhan Sian Medical Technology Co., LtdAcute Lymphoblastic Leukemia, B Cell Lymphoma

Start: 2016-05-01End: 2021-06-01Target: 20Updated: 2018-11-20

Phase 4

Busulfan Pharmacokinetic Analysis and GST Polymorphism in Adults Undergoing Hematological Stem Cell Transplantation

WithdrawnNCT01071486

Rambam Health Care CampusBusulfan Pharmacokinetic Analysis, GST Genetic Polymorphism

Start: 2009-08-31End: 2012-10-31Updated: 2015-11-10